|
|
|
|
| LEADER |
03995nam a22003135i 4500 |
| 001 |
000286072 |
| 005 |
20210524093508.0 |
| 007 |
cr nn 008mamaa |
| 008 |
131120s2014 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781627037273
|
| 024 |
7 |
|
|a 10.1007/978-1-62703-727-3
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Molecular Diagnostics for Melanoma :
|b Methods and Protocols /
|c edited by Magdalena Thurin, Francesco M. Marincola.
|
| 250 |
|
|
|a 1st ed. 2014.
|
| 260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2014.
|
| 300 |
|
|
|a XXIII, 712 p. 110 illus., 94 illus. in color. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Methods in Molecular Biology,
|v 1102
|
| 505 |
0 |
|
|a Novel Insights/translational Implication from the Emerging Biology of Melanoma -- Emerging Clinical Issues in Melanoma in the Molecularly Targeted Era -- Integrating Molecular Biomarkers Into Current Clinical Management In Melanoma -- Advances in Adjuvant Therapy: Potential for Prognostic and Predictive Biomarkers -- Immunologic Monitoring of Cancer Vaccine Trials Using the ELISPOT Assay -- Markers for Anti-Cytotoxic T-lymphocyte Antigen 4 (CTLA-4) Therapy in Melanoma -- Marker Utility for Combination Therapy -- Assaying for BRAF V600E in Tissue and Blood in Melanoma -- Selecting Patients for KIT Inhibition in Melanoma -- Detecting Mechanisms of Acquired BRAF inhibitor Resistance in Melanoma -- Current Status of Diagnostic and Prognostic Markers in Melanoma -- Chromosomal Copy Number Analysis in Melanoma Diagnostics -- Construction and Analysis of Multi-Parameter Prognostic Models for Melanoma Outcome -- Immunohistochemical Diagnostic and Prognostic Markers for Melanoma -- Lymphatic Invasion as a Prognostic Biomarker in Primary Cutaneous Melanoma -- Tumor Infiltrating Lymphocytes and Their Significance in Melanoma Prognosis -- Pathological Staging of Melanoma -- Genotyping of Human Leukocyte Antigen (HLA) Ancestral Haplotypes as Prognostic Marker in Cancer Using PCR Analysis -- B7-H Abnormalities in Melanoma and Clinical Relevance -- Melanoma Susceptibility Genes and Risk Assessment -- Clinical, Pathologic, and Imaging Features, and Biological Markers of Uveal Melanoma -- A Prognostic Test to Predict Risk of Metastasis in Uveal Melanoma Based on a 15-Gene Expression Profile -- Molecular Karyotyping for Detection of Prognostic Markers in Fine Needle Aspirate Biopsy Samples of Uveal Melanoma -- ERBB4 Mutation Analysis: Emerging Molecular Target for Melanoma Treatment -- Epigenetic Markers of Prognosis in Melanoma -- Isolation of Melanoma Cell Subpopulations Using Negative Selection -- Circulating Tumor Cells as Prognostic Biomarkers in Cutaneous Melanoma Patients -- Detection of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Melanoma -- Targeting Damage Associated Molecular Pattern Molecules (DAMPs) and DAMP Receptors in Melanoma -- The Clinical Use of PET/CT in the Evaluation of Melanoma -- Immune System Functional Pathway Analysis Using Single Cell Network Profiling (SCNP): A Novel Tool in Cancer Immunotherapy -- Quantitative and Spatial Image Analysis of Tumor and Draining Lymph Nodes Using Immunohistochemistry and High Resolution Multispectral Imaging to Predict Metastasis -- COLD-PCR Enriches Low-Level Variant DNA Sequences and Increases the Sensitivity of Genetic Testing -- Isolation of Circulating MicroRNAs from Microvesicles found in Human Plasma -- Detection of Circulating Tumor Cells by Photoacustic Flowmetry -- Statistical Design and Evaluation of Biomarker Studies -- Tissue Resources for Clinical Use and Marker Studies in Melanoma.
|
| 650 |
|
0 |
|a Cancer research.
|
| 650 |
|
0 |
|a Oncology .
|
| 650 |
1 |
4 |
|a Cancer Research.
|
| 650 |
2 |
4 |
|a Oncology.
|
| 700 |
1 |
|
|a Thurin, Magdalena.
|e editor.
|
| 700 |
1 |
|
|a Marincola, Francesco M.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|